ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...

A Coralville CrossFit community held a fundraiser Friday for a local boy diagnosed with Pediatric Autoimmune Neuropsychiatric ...

NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Today, EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices announced that its subsidiary closed a successful $8 million ...

Q4 2025 Earnings Call February 25, 2026 4:30 PM ESTCompany ParticipantsAdam Grossman - Co-Founder, President, CEO ...

"The next day, my son convinced me to go to a walk-in clinic. They ran some tests and immediately sent me to the ER. I had been bleeding internally the whole time from a duodenal ulcer, which required ...

Graham Holdings Co reports fourth-quarter earnings Friday, with analysts expecting the diversified conglomerate to post earnings of $11.59 per share on revenue of $1.27 billion. The results would mark ...

In 1996, a previously healthy 5-year-old girl presented to a local urgent care clinic with a 3-day history of fever and a progressive, generalized vesicular rash, diagnosed as varicella with a known ...

For decades, complex infused therapies were anchored to hospitals. Higher acuity was assumed to require inpatient walls, and infusion centers were viewed primarily as transitional sites rather than ...

Mordor Intelligence has published a new report on immunoglobulin market offering a comprehensive analysis of trends, growth drivers, and future projections.

Hopes that anti-tau drugs could join those targeting amyloid as treatments for Alzheimer's disease have been dented by the failure of a phase 2b trial of Johnson & Johnson's posdinemab. The AuTonomy ...

Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...